The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2013
At a glance
- Drugs Galantamine (Primary) ; Nimodipine
- Indications Alzheimer's disease; Vascular dementia
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 22 Jul 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 22 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2009 Actual patient number (22) added as reported by ClinicalTrials.gov.